Ledger.Open graph →
SEC Form D · filed October 27, 2011

NAPO PHARMACEUTICALS INC

Offering
$5.0M
Sold
$3.1M
Exemption
—
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

People & firms on this filing (14)

William Baquet · New York, NYExecGregory Stock · San Francisco, CADirectorSir William Young · San Francisco, CADirectorThomas Van Dyck · San Francisco, CADirectorPravi Chaturvedi · San Francisco, CAExecDennis Fenton · Calabasas, CADirectorKate Adams · Boston, MAExecJeffrey S. Froikin-Gordon · Washington, Washington, D.C.ExecPatrick Agemian · Grand Cayman, Cayman IslandsExecJohn P. Martinsen · Minneapolis, MNDirectorR. S. Egginton · Minneapolis, MNDirectorJohn W. Walsh · Minneapolis, MNDirectorTarra Victorino · Sacramento, CAExecDennis Fenton · Nutley, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗